Home › Biogen Inc (BIIB) Rating Increased to Overweight at Piper Jaffray
 

Keywords :   


Biogen Inc (BIIB) Rating Increased to Overweight at Piper Jaffray

2016-01-03 18:15:54| Biotech - Topix.net

In related news, CMO Alfred Sandrock sold 441 shares of the business's stock in a transaction that occurred on Friday, December 4th. The stock was sold at an average price of $277.00, for a total transaction of $122,157.00.

Tags: rating increased piper overweight

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
26.06VW to invest up to $5bn in Tesla rival Rivian
26.06Strategic use of soybean meal to maximize hog carcass weight during summer
26.06Eastern North Pacific Tropical Weather Outlook
26.06Atlantic Tropical Weather Outlook
26.06Aer Lingus pilots begin industrial action over pay dispute
25.06Water requirements in the summer
25.06New model Is transforming the study of liver abscesses in cattle
25.06Royal Mail buyer to make offer for all staff shares
More »